Madrigal’s Rezdiffra Brings In $14.6m During Its First Quarter

Share Price Declines On Various Concerns

 
• By Joseph Haas
  
Madrigal's Rezdiffra is off to a solid launch, although some investors disagree
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip